Stay updated on XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.

Latest updates to the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The study record and its listed history entries remain unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedA banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.6%

- Check35 days agoChange DetectedA new study-record version dated October 13, 2026, was added to the history with a study-status update. The current record lists the study as suspended.SummaryDifference0.4%

- Check42 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study history adds a new Revision: v3.7.0 entry and removes the previous Revision: v3.6.6 entry, indicating an update to the history log rather than substantive changes to the trial data.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history now shows a new Revision: v3.6.6 entry and removes the previous Revision: v3.6.5 from the log, representing a page version update in the study record history. This captures the latest UI/version change reflected in the study's revision history.SummaryDifference0.1%

Stay in the know with updates to XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.